Applied Energetics to Participate in Two Industry Panels at the 38th Annual ROTH Conference

Defense and Space Infrastructure Drones & Robotics are Transforming Industry, Compliance and Defense TUCSON, AZ / ACCESS Newswire / March 20, 2026 / Applied Energetics (OTCQB:AERG), a leader in advanced directed-energy and ultrashort-pulse laser technologies, today announced that Chris Donaghey, Chief Executive Officer, will be participating in the following industry panel discussions at the 38th […]

Investor Summit Announces Q1 Presenter Line Up (Presentations 3/25, 1-on-1s 3/26)

NEW YORK, NY / ACCESS Newswire / March 20, 2026 / The Investor Summit today announced the lineup of public companies scheduled to present at its upcoming Virtual March 25-26, 2026 event. Event Details:Virtual Presentations on Wednesday March 25, 2026Virtual Meetings on Thursday March 26, 2026 Request Access to 1×1 meetings:[Click here] The Investor Summit

Augusta Precious Metals Commits to Ongoing Support of Until Forever, Helping Families Affected by Violence

America’s Premiere Gold IRA Company Continues Championing Victims of Violence, in Alignment with Its Culture of Caring WESTON, FL / ACCESS Newswire / March 20, 2026 / Until Forever, a nonprofit organization supporting families affected by senseless violence, announced that Augusta Precious Metals – a company that empowers American investors to protect retirement with physical

Pomerantz LLP Alerts Shareholders to Investor Suit Involving Trip.com Group Limited – TCOM

NEW YORK CITY, NY / ACCESS Newswire / March 20, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Trip.com Group Limited ("Trip.com" or the "Company") (NASDAQ:TCOM).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

Pomerantz LLP Calls Attention to Class Action Against Boston Scientific Corporation – BSX

NEW YORK CITY, NY / ACCESS Newswire / March 20, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Boston Scientific Corporation ("Boston Scientific" or the "Company") (NYSE:BSX).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail

Pomerantz LLP Announces Securities Class Action Lawsuit Against Nektar Therapeutics, Inc. – NKTR

NEW YORK CITY, NY / ACCESS Newswire / March 20, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Nektar Therapeutics ("Nektar" or the "Company") (NASDAQ:NKTR) and certain officers.�� The class action, filed in the United States District Court for the Northern District of California, and docketed under 26-cv-01951, is

AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / March 20, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Aquestive Therapeutics, Inc. (NASDAQ:AQST) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the

Pomerantz LLP Moves to File Class Action Against Lakeland Industries, Inc. – LAKE

NEW YORK CITY, NY / ACCESS Newswire / March 20, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Lakeland Industries, Inc. ("Lakeland" or the "Company") (NASDAQ:LAKE) and certain officers.�� The class action, filed in the United States District Court for the Southern District of New York, and docketed under

TCPC SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that BlackRock TCP Capital Corp. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESS Newswire / March 20, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against BlackRock TCP Capital Corp. (NASDAQ:TCPC) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of

Pomerantz LLP Reminds Investors: Securities Lawsuit Has Been Filed Against Ultragenyx Pharmaceutical Inc. – RARE

NEW YORK CITY, NY / ACCESS Newswire / March 20, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Ultragenyx Pharmaceutical Inc. ("Ultragenyx" or the "Company") (NASDAQ:RARE).�� Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are

Scroll to Top